Page last updated: 2024-08-17

medroxyprogesterone acetate and Cervix Dysplasia

medroxyprogesterone acetate has been researched along with Cervix Dysplasia in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.25)18.7374
1990's3 (18.75)18.2507
2000's7 (43.75)29.6817
2010's5 (31.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baik, S; Chung, SH; Mehta, FF1
Bazuaye, PE; Fletcher, HM; Jackson, MD; McFarlane-Anderson, N; Smikle, M1
Feng, Q; Harris, TG; Kiviat, NB; Koutsky, LA; Kulasingam, SL; Miller, L; Schwartz, SM1
Baras, AS; Darracott, MM; Martirosian, TE; Smith, SC1
Clark, MK; Nichols, S; Railsback, L; Stockdale, CK1
Datta, SD; Ghanem, KG; Hagensee, M; Hsu, K; Kerndt, P; Koutsky, LA; Shlay, JC; Unger, ER1
Blumenthal, PD; Bright, PL; Kwok, C; Morrison, CS; Norris Turner, A; Royce, RA; Tucker, HO; Wong, EL; Yacobson, I1
Bisgrove, EZ; Cousins, DS; Fortney, JA; Gaines, MM; Hoyo, C; Schwingl, PJ1
Hoekstra, AV; Huh, WK; Kosinski, A1
Hendrix, SL; Hubbell, FA; Johnson, SR; Lane, DS; Pettinger, M; Romano, PS; Yasmeen, S1
McGoldrick, IA1
Schantz, HD; Trabal, JF; Valente, PT1
Jax, JM; Kuntzman, TJ; Volk, EE1
Agarwal, SK; Barnabei, VM; Bass, K; Grady, D; Kerlikowske, K; Mandelblatt, J; Pickar, JH; Sawaya, GF; Snyder, TE; Valleur, JL1

Reviews

1 review(s) available for medroxyprogesterone acetate and Cervix Dysplasia

ArticleYear
Depo provera in perspective.
    Papua and New Guinea medical journal, 1981, Volume: 24, Issue:4

    Topics: Adenocarcinoma; Animals; Breast Neoplasms; Contraceptive Agents, Female; Dogs; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Pregnancy; Uterine Cervical Dysplasia; Uterine Neoplasms

1981

Trials

2 trial(s) available for medroxyprogesterone acetate and Cervix Dysplasia

ArticleYear
Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial.
    Obstetrics and gynecology, 2006, Volume: 108, Issue:2

    Topics: Aged; Aging; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Health Promotion; Health Services for the Aged; Humans; Incidence; Longitudinal Studies; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Proportional Hazards Models; Treatment Outcome; United States; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears; Women's Health Services

2006
The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS).
    Annals of internal medicine, 2000, Dec-19, Volume: 133, Issue:12

    Topics: Aged; Cervix Uteri; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); False Positive Reactions; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Postmenopause; Predictive Value of Tests; Prospective Studies; Surveys and Questionnaires; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears

2000

Other Studies

13 other study(ies) available for medroxyprogesterone acetate and Cervix Dysplasia

ArticleYear
Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model.
    The American journal of pathology, 2019, Volume: 189, Issue:12

    Topics: Animals; Antineoplastic Agents, Hormonal; Female; Humans; Medroxyprogesterone Acetate; Mice; Mice, Inbred CBA; Mice, Transgenic; Papillomaviridae; Papillomavirus Infections; Receptors, Progesterone; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2019
Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women.
    BMC women's health, 2008, May-30, Volume: 8

    Topics: Adult; Case-Control Studies; Contraceptive Devices; Contraceptives, Oral, Hormonal; Female; Health Knowledge, Attitudes, Practice; Humans; Jamaica; Medroxyprogesterone Acetate; Middle Aged; Papanicolaou Test; Risk Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears; Women's Health

2008
Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection.
    American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:5

    Topics: Adolescent; Adult; Biopsy; Case-Control Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Papillomavirus Infections; Risk Factors; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult

2009
Depot medroxyprogesterone acetate: a risk factor for cervical stenosis after loop electrosurgical excisional procedure management of cervical intraepithelial neoplasia?
    Journal of lower genital tract disease, 2010, Volume: 14, Issue:1

    Topics: Adult; Constriction, Pathologic; Contraceptive Agents, Female; Delayed-Action Preparations; Electrosurgery; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postoperative Complications; Risk Factors; Uterine Cervical Diseases; Uterine Cervical Dysplasia; Young Adult

2010
Differences in cervical cytologic and histologic findings between women using depot-medroxyprogesterone acetate and oral contraceptives.
    Journal of lower genital tract disease, 2011, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Cervix Uteri; Colposcopy; Contraceptive Agents, Female; Contraceptives, Oral; Delayed-Action Preparations; False Positive Reactions; Female; Humans; Iowa; Logistic Models; Medroxyprogesterone Acetate; Retrospective Studies; Risk Factors; Smoking; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult

2011
The association of current hormonal contraceptive use with type-specific HPV detection.
    Sexually transmitted infections, 2011, Volume: 87, Issue:5

    Topics: Adolescent; Adult; Aged; Coitus; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Human papillomavirus 16; Humans; Medroxyprogesterone Acetate; Middle Aged; Papillomavirus Infections; Risk Factors; Sentinel Surveillance; Sexual Partners; Uterine Cervical Dysplasia; Young Adult

2011
Hormonal contraception and area of cervical ectopy: a longitudinal assessment.
    Contraception, 2011, Volume: 84, Issue:5

    Topics: Adolescent; Adult; Baltimore; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Prospective Studies; Uterine Cervical Dysplasia; Young Adult

2011
Depo medroxyprogesterone acetate (DMPA) and combined oral contraceptives and cervical carcinoma in-situ in women aged 50 years and under.
    The West Indian medical journal, 2004, Volume: 53, Issue:6

    Topics: Adolescent; Adult; Case-Control Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Humans; Jamaica; Medroxyprogesterone Acetate; Middle Aged; Risk Factors; Time Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2004
Hormonal contraception and false-positive cervical cytology: is there an association?
    Journal of lower genital tract disease, 2006, Volume: 10, Issue:2

    Topics: Adult; Carcinoma in Situ; Case-Control Studies; Cervix Uteri; Colposcopy; Contraceptive Agents, Female; False Positive Reactions; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Multivariate Analysis; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears

2006
Risk of cervical dysplasia in users of oral contraceptives, intrauterine devices or depot-medroxyprogesterone acetate. The New Zealand Contraception and Health Study Group.
    Contraception, 1994, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Contraceptives, Oral; Female; Humans; Intrauterine Devices; Medroxyprogesterone Acetate; New Zealand; Prospective Studies; Risk Factors; Uterine Cervical Dysplasia

1994
History of long-term use of depot-medroxyprogesterone acetate in patients with cervical dysplasia; case-control analysis nested in a cohort study. The New Zealand Contraception and Health Study Group.
    Contraception, 1994, Volume: 50, Issue:5

    Topics: Adult; Age Factors; Case-Control Studies; Cohort Studies; Coitus; Cytodiagnosis; Female; Humans; Medroxyprogesterone Acetate; New Zealand; Prospective Studies; Risk Factors; Sexual Partners; Smoking; Uterine Cervical Dysplasia

1994
Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone acetate.
    Cancer, 1998, Dec-25, Volume: 84, Issue:6

    Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; False Positive Reactions; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Papanicolaou Test; Precancerous Conditions; Progesterone Congeners; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears

1998
Cytologic findings in cervical smears in patients using intramuscular medroxyprogesterone acetate (Depo-provera) for contraception.
    Diagnostic cytopathology, 2000, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Cervix Uteri; Contraceptive Agents, Female; Female; Glycogen; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Precancerous Conditions; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears

2000